Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer

The distinct hormone molecules and receptors, such as follicle-stimulating hormone receptor (FSHR) in ovarian cancer, provide opportunities for more precisely targeted therapy. We previously developed FSHR-mediated nanoparticles and found that FSH peptides on the surface of nanoparticles improved th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Shan-Shan, Zhang, Ming-Xing, Zhang, Meng, Yu, Yi, Chen, Jun, Zhang, Xiao-Yan, Xu, Cong-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058603/
https://www.ncbi.nlm.nih.gov/pubmed/29461120
http://dx.doi.org/10.1080/10717544.2018.1440667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058603/
https://www.ncbi.nlm.nih.gov/pubmed/29461120
http://dx.doi.org/10.1080/10717544.2018.1440667

Ejemplares similares